Jan 19, 2021 | False Claims Act
In a press release on January 14, the U.S. Department of Justice released its False Claims Act Statistics for Fiscal Year 2020. In total, the federal government recovered over $2.2 billion in settlements and judgments from False Claims Act cases brought against...
Jan 15, 2021 | False Claims Act
The DOJ announced it recently settled with durable medical equipment supplier Apria Healthcare to resolve allegations of fraudulent billing practices related to the rental of non-invasive ventilators (“NIVs”). The case was originally brought in the Southern District...
Jan 15, 2021 | COVID-19 Related Law, False Claims Act, Fraud Investigations
In April 2020, CG attorneys wrote about the increased risk of government scrutiny for recipients of the CARES Act Paycheck Protection Program (PPP), which initially provided over $349 billion in forgivable PPP loans to small businesses. As Congress authorized hundreds...
Dec 22, 2020 | False Claims Act
In July 2020, CG attorneys discussed two settlements by Novartis Pharmaceuticals Corporation for $729 million involving allegations that Novartis paid kickbacks to doctors and patients. One settlement involved Novartis agreeing to pay $51.25 million to resolve...
Dec 10, 2020 | False Claims Act
On December 4, 2020, the U.S. Department of Health and Human Services (HHS) announced the creation of the False Claims Act Working Group (FCA Working Group). The federal False Claims Act (FCA) has remained one of the federal government’s top tools to investigate and...
Dec 2, 2020 | False Claims Act
On November 6, 2020, a D.C. District Court judge ruled that a whistleblower bringing a suit under the False Claims Act (FCA) need not allege “materiality” when relying on the “fraud in the inducement” theory of falsity. Over the years, Congress and federal agencies...
